# Reyedar BV.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/reyedar

- Industry: Healthcare Specialists
- Headquarters: Groningen, Netherlands
- Website: www.reyedar.com
- Total disclosed funding: $3.3M
- Latest round: Seed (Jul 5, 2023)
- Investors on record: 5

## About

Based in the Netherlands, and founded in 2019, Reyedar BV. formerly known as Reperio Medtech, is a spin-off company of the Ophthalmology Department of the University Medical Center, and operates as a deep-tech company that offers accessible solutions for the screening of visual and neurodegenerative diseases. In July 2023, Reyedar raised EUR 3 million in seed funding led by Cottonwood Technology Fund, with participation from N.V. NOM, Pupil Labs, Uneti Ventures, and returning investor Blue Sparrows MedTech Fund. As of July 2023, the company is led by its CEO, Dr. Alessandro Grillini.

Reyedar BV offers AI-powered infrared eye-tracking glasses to measure eye movement reactions, which are analyzed by algorithms based on signal processing and deep neural networks. The algorithm translates eye-tracking data into clinically relevant information and generates interpretive reports that include visual field sensitivity screening and qualitative risk indications for neuro visual disorders.

The company plans to use the seed funding to expand its team and launch its eye care product as it moves to commercialize its technology.

## Funding rounds

- Seed, Jul 5, 2023, $3.3M — Cottonwood Technology Fund, NOM, Blue Sparrows MedTech Fund, UNETI Ventures, Pupil Labs

## Investors

- Cottonwood Technology Fund (https://capitalatlas.ai/funds/cottonwood-technology-fund) — Seed
- NOM (https://capitalatlas.ai/funds/nom) — Seed
- Blue Sparrows MedTech Fund (https://capitalatlas.ai/funds/blue-sparrows-medtech-fund) — Seed
- UNETI Ventures (https://capitalatlas.ai/funds/uneti-ventures) — Seed
- Pupil Labs — Seed